Literature DB >> 56883

Sudden death following intravenous sodium diphenylhydantoin.

S Zoneraich, O Zoneraich, J Siegel.   

Abstract

A well-documented (by ECG as well as autopsy) case of fatal ventricular asystole secondary to intravenous administration of sodium diphenylhydantoin is presented. The possible role of ventricular conduction disturbances, hypoxemia, and metabolic abnormalities as precipitating factors are discussed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 56883     DOI： 10.1016/s0002-8703(76)80223-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 2.  Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.

Authors:  J C DeToledo; R E Ramsay
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

3.  Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase.

Authors:  A Dasgupta; E Schlette
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels.

Authors:  A Levati; G Savoia; F Zoppi; L Boselli; C Tommasino
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 5.  Cardiovascular adverse effects of phenytoin.

Authors:  B Guldiken; J Rémi; Soheyl Noachtar
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

Review 6.  New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.

Authors:  M Bebin; T P Bleck
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.